Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Veterinary Vaccine Import to Russia (June and First Half of 2020)

Friday, August 14, 2020

Between January and June 2020, Russia imported 6.29 bln RUB worth of veterinary vaccines (customs clearance included), which is in monetary terms (rubles) 13% higher than in 2019, even though the importers stocked up their warehouses in late 2019. The import volume of veterinary vaccines in 2019 has grown by more than 37%. In the first half of 2020, the import volume amounted to 3.39 mln units, with the dynamics of +0.4%. If calculated in dosages, the dynamics are -6.7%, and the import volume is 23.32 bln dosages.

Live vaccines account for the largest volume both in physical and monetary terms, with the dynamics of +39% in rubles. If calculated in dosages, the dynamics are -7.5%. As for inactivated vaccines, the dynamics are -12.6% in monetary and +28% in physical terms. Combined vaccines accounts for less than 0.02% of the total import volume in MDUs, but for as much as 7.4% in rubles, with the dynamics of +11% in monetary and +20% in physical terms.

MSD accounts for the biggest import volume of live vaccines, with 36% of the volume in monetary terms. The dynamics in rubles are +53%, which is, however, far from record-worthy, compared with Elanco (USA) and Biofarm (Czech). Elanco’s and Biofarm’s imports have grown by 2.5 and 2.2 times, respectively. Elanco was importing only their AviPro line, which includes five types of vaccines. Vaccines for the prevention of viral anemia in chicken, infectious bursal disease and Newcastle disease contributed to the dynamics the most. Biofarm’s import line was much narrower: the company was importing only Livacox, vaccine for the prevention of chicken coccidiosis.

Daesung Microbiological Labs (South Korea) and Pharmagal-Bio (Slovenia) have the highest dynamics of the import of inactivated vaccines (import grown by 3.9 and 3 times in monetary terms, respectively). Daesung Microbiological Labs was importing two vaccines, and Circo PigVac, vaccine for the prevention of circovirus infection in swine, was the one that contributed to the dynamics better. Pharmagal-Bio was importing only Rotagal, vaccine for the prevention of rotavirus, coronavirus infection and colibacillosis in cattle.

As for combined vaccines, Zoetis has the highest import dynamics (import grown by 2.4 times in monetary terms). The company was importing three trademarks, with CattleMaster contributing to the dynamics the most.

Dynamics of veterinary vaccine import to Russia (EEU countries excluded), free circulation prices (customs clearance and VAT included), 2016 – 2019, Q1 – Q2 2020, bln RUB